Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aldosteronism and hypertension.

David A Calhoun1

  • 1Vascular Biology and Hypertension Program, Sleep/Wake Disorders Center, University of Alabama at Birmingham, Birmingham, Alabama, USA. dcalhoun@uab.edu

Clinical Journal of the American Society of Nephrology : CJASN
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spironolactone improves left atrial function and atrioventricular coupling in patients with resistant hypertension.

The international journal of cardiovascular imaging·2023
Same author

Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2023
Same author

Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension.

Hypertension (Dallas, Tex. : 1979)·2022
Same author

Diastolic function: modeling left ventricular untwisting as a damped harmonic oscillator.

Physiological measurement·2022
Same author

Elucidation of obstructive sleep apnoea related blood pressure surge using a novel continuous beat-to-beat blood pressure monitoring system.

Journal of hypertension·2021
Same author

Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change.

Journal of the American Heart Association·2021

High aldosterone levels are linked to developing and worsening high blood pressure (hypertension), even independently of the renin system. This suggests aldosterone plays a key role in hypertension, particularly in obese individuals.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Hypertension Research

Background:

  • Hyperaldosteronism is increasingly recognized as a significant factor in hypertension.
  • Evidence links aldosterone to both the development and severity of high blood pressure.
  • Aldosterone may contribute to resistance to standard antihypertensive therapies.

Purpose of the Study:

  • To investigate the association between aldosterone levels and blood pressure.
  • To explore the role of aldosterone in hypertension, particularly in relation to obesity and the renin-angiotensin system.
  • To examine the predictive value of baseline aldosterone for future hypertension development.

Main Methods:

  • Cross-sectional analyses correlating plasma aldosterone levels with blood pressure (BP) in individuals, with a focus on obese subjects.

Related Experiment Videos

  • Examination of the relationship between BP and plasma renin activity in the same cohort.
  • Prospective analysis of baseline serum aldosterone and subsequent hypertension development over a 4-year follow-up period.

    • Main Results:

    • Plasma aldosterone levels correlate with BP, especially in obese individuals.
    • In obese individuals, BP was not related to plasma renin activity, suggesting an aldosterone effect independent of the renin-angiotensin II system.
    • Baseline serum aldosterone was a strong predictor of hypertension development over 4 years.

    Conclusions:

    • Aldosterone significantly contributes to hypertension development and severity.
    • The effect of aldosterone on BP may be independent of the renin-angiotensin system, particularly in obese populations.
    • Elevated aldosterone is a risk factor for developing hypertension.